| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-10-17 | 4,774 | $3.08 | $14.70kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-10-17 | 7,833 | $0.75 | $5.87kBuy |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-10-17 | 2,072 | $3.08 | $6.38kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-10-17 | 3,400 | $0.75 | $2.55kBuy |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-07-14 | 11,881 | $3.32 | $39.48kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-07-11 | 11,874 | $3.33 | $39.49kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-07-10 | 11,617 | $3.40 | $39.47kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-07-09 | 11,247 | $3.51 | $39.48kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-07-08 | 10,824 | $3.51 | $38.02kSell |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2025-03-09 | 7,690 | $2.39 | $18.38kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jeffrey Lawrence Schwartz | 19.11% | 8,448,860 | $24.76M | Insider |
| Bain Capital Life Sciences Investors LLC | 19.08% | 8,434,560 | $24.71M | Insider |
| Bain Capital Life Sciences Investors LLC | 19.08% | 8,434,560 | $24.71M | Institution |
| Longitude Capital Partners II LLC | 8.19% | 3,621,866 | $10.61M | Insider |
| David Hirsch | 7.74% | 3,422,252 | $10.03M | Insider |
| Kennedy Lewis Management LP | 6.57% | 2,904,490 | $8.51M | Insider |
| Abgwtt Global Life Science Capital Partners GP Ltd | 4.18% | 1,848,296 | $5.42M | Institution |
| Richard S. Kollender | 3.60% | 1,592,027 | $4.66M | Insider |
| Schonfeld Strategic Advisors LLC | 2.35% | 1,037,668 | $3.04M | Institution |
| Robert G. Spignesi Jr. | 2.21% | 974,937 | $2.86M | Insider |